[An unusually severe allergic dermatitis after use of BAL (sulfactin)].
D004112:Dimercaprol / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology*
D004112:Dimercaprol
BAL/therapeutic use; DERMATITIS MEDICAMENTOSA/etiology and pathogenesis
Uber eine ungewöhnlich schwere allergische Dermatitis nach Anwendung von BAL (Sulfactin).